ALA 0.00% 15.5¢ arovella therapeutics limited

what was the point in that Suda newsletter, one release in mid...

  1. 466 Posts.
    lightbulb Created with Sketch. 76
    what was the point in that Suda newsletter, one release in mid January and then never heard from them again.

    hopper and team your communication really sucks at the moment. Where does each project stand? Where the hell is the update on TGA approval for Zolpimist? If they asked for more information, tell us.

    sick of the same media presentations as well - we get it, we understand what you do and how the technology works. DO SOMETHING WITH IT TO DRIVE SHAREHOLDER VALUE.

    pathetic


 
watchlist Created with Sketch. Add ALA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.